Deltex Medical Group plc
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler and pulse contour analysis and monitoring platform. It offers dopplink, a patient interface cable; and pressurewave, an arterial blood pressure signal under the TrueVue brand. The company also provides oesophageal doppler monitoring systems. Deltex Medical Group plc was incorporated in 2… Read more
Deltex Medical Group plc (DTXMF) - Net Assets
Latest net assets as of December 2024: $1.45 Million USD
Based on the latest financial reports, Deltex Medical Group plc (DTXMF) has net assets worth $1.45 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.39 Million) and total liabilities ($2.93 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.45 Million |
| % of Total Assets | 33.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | -44.98% |
| 10-Year Change | -24.48% |
| Growth Volatility | 47.47 |
Deltex Medical Group plc - Net Assets Trend (1998–2024)
This chart illustrates how Deltex Medical Group plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Deltex Medical Group plc (1998–2024)
The table below shows the annual net assets of Deltex Medical Group plc from 1998 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.45 Million | -53.77% |
| 2023-12-31 | $3.14 Million | +41.07% |
| 2022-12-31 | $2.23 Million | +17.14% |
| 2021-12-31 | $1.90 Million | -27.98% |
| 2020-12-31 | $2.64 Million | -0.53% |
| 2019-12-31 | $2.65 Million | +10.07% |
| 2018-12-31 | $2.41 Million | +85.54% |
| 2017-12-31 | $1.30 Million | -46.21% |
| 2016-12-31 | $2.42 Million | +25.62% |
| 2015-12-31 | $1.92 Million | -60.51% |
| 2014-12-31 | $4.87 Million | +44.44% |
| 2013-12-31 | $3.37 Million | +60.24% |
| 2012-12-31 | $2.10 Million | +13.42% |
| 2011-12-31 | $1.86 Million | +83.94% |
| 2010-12-31 | $1.01 Million | -43.91% |
| 2009-12-31 | $1.80 Million | +82.83% |
| 2008-12-31 | $984.00K | -28.70% |
| 2007-12-31 | $1.38 Million | +79.22% |
| 2006-12-31 | $770.00K | -28.44% |
| 2005-12-31 | $1.08 Million | -46.04% |
| 2004-12-31 | $1.99 Million | -27.49% |
| 2003-12-31 | $2.75 Million | -5.17% |
| 2002-12-31 | $2.90 Million | -50.85% |
| 2001-12-31 | $5.90 Million | +20.41% |
| 2000-12-31 | $4.90 Million | +547.49% |
| 1999-12-31 | $-1.09 Million | -442.08% |
| 1998-12-31 | $-202.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Deltex Medical Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4674500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.25 Million | 453.31% |
| Other Comprehensive Income | $17.96 Million | 1122.81% |
| Other Components | $35.69 Million | 2230.31% |
| Total Equity | $1.60 Million | 100.00% |
Deltex Medical Group plc Competitors by Market Cap
The table below lists competitors of Deltex Medical Group plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alam Sutera Realty Tbk
JK:ASRI
|
$76.41 Million |
|
Jutal Offshore Oil Services Ltd
PINK:JUTOF
|
$76.42 Million |
|
Multi Bintang Indonesia Tbk
JK:MLBI
|
$76.43 Million |
|
Nordic Mining ASA
OL:NOM
|
$76.49 Million |
|
Eltel AB (publ)
F:E5E
|
$76.39 Million |
|
Hikal Limited
NSE:HIKAL
|
$76.33 Million |
|
Chesapeake Finl Shs
OTCQX:CPKF
|
$76.32 Million |
|
Perfect Group Corp Ltd Class A
SHG:603059
|
$76.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Deltex Medical Group plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,289,000 to 1,600,000, a change of -1,689,000 (-51.4%).
- Net loss of 1,797,000 reduced equity.
- Other comprehensive income decreased equity by 239,000.
- Other factors increased equity by 347,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.80 Million | -112.31% |
| Other Comprehensive Income | $-239.00K | -14.94% |
| Other Changes | $347.00K | +21.69% |
| Total Change | $- | -51.35% |
Book Value vs Market Value Analysis
This analysis compares Deltex Medical Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 112.68x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $-0.01 | $0.10 | x |
| 1999-12-31 | $-0.03 | $0.10 | x |
| 2000-12-31 | $0.14 | $0.10 | x |
| 2001-12-31 | $0.16 | $0.10 | x |
| 2002-12-31 | $0.08 | $0.10 | x |
| 2003-12-31 | $0.05 | $0.10 | x |
| 2004-12-31 | $0.03 | $0.10 | x |
| 2005-12-31 | $0.02 | $0.10 | x |
| 2006-12-31 | $0.01 | $0.10 | x |
| 2007-12-31 | $0.02 | $0.10 | x |
| 2008-12-31 | $0.01 | $0.10 | x |
| 2009-12-31 | $0.02 | $0.10 | x |
| 2010-12-31 | $0.01 | $0.10 | x |
| 2011-12-31 | $0.01 | $0.10 | x |
| 2012-12-31 | $0.01 | $0.10 | x |
| 2013-12-31 | $0.02 | $0.10 | x |
| 2014-12-31 | $0.03 | $0.10 | x |
| 2015-12-31 | $0.01 | $0.10 | x |
| 2016-12-31 | $0.01 | $0.10 | x |
| 2017-12-31 | $0.00 | $0.10 | x |
| 2018-12-31 | $0.01 | $0.10 | x |
| 2019-12-31 | $0.01 | $0.10 | x |
| 2020-12-31 | $0.01 | $0.10 | x |
| 2021-12-31 | $0.00 | $0.10 | x |
| 2022-12-31 | $0.00 | $0.10 | x |
| 2023-12-31 | $0.00 | $0.10 | x |
| 2024-12-31 | $0.00 | $0.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Deltex Medical Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -112.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -87.40%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 2.74x
- Recent ROE (-112.31%) is below the historical average (-95.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 0.00% | -713.23% | 0.31x | 0.00x | $-2.68 Million |
| 1999 | 0.00% | -359.80% | 0.62x | 0.00x | $-2.77 Million |
| 2000 | -79.59% | -390.00% | 0.19x | 1.10x | $-4.39 Million |
| 2001 | -55.93% | -253.85% | 0.18x | 1.20x | $-3.89 Million |
| 2002 | -100.00% | -161.11% | 0.46x | 1.34x | $-3.19 Million |
| 2003 | -86.98% | -77.56% | 0.81x | 1.39x | $-2.67 Million |
| 2004 | -138.11% | -110.43% | 0.84x | 1.48x | $-2.95 Million |
| 2005 | -162.55% | -57.50% | 1.38x | 2.04x | $-1.86 Million |
| 2006 | -258.96% | -56.79% | 1.54x | 2.96x | $-2.07 Million |
| 2007 | -158.55% | -52.50% | 1.36x | 2.22x | $-2.33 Million |
| 2008 | -259.86% | -48.84% | 1.53x | 3.48x | $-2.66 Million |
| 2009 | -110.51% | -35.25% | 1.13x | 2.77x | $-2.17 Million |
| 2010 | -145.49% | -23.38% | 1.44x | 4.33x | $-1.57 Million |
| 2011 | -76.56% | -22.54% | 1.12x | 3.03x | $-1.61 Million |
| 2012 | -99.43% | -30.88% | 1.08x | 2.97x | $-2.30 Million |
| 2013 | -62.59% | -29.45% | 0.93x | 2.28x | $-2.44 Million |
| 2014 | -59.57% | -45.35% | 0.68x | 1.94x | $-3.45 Million |
| 2015 | -165.79% | -54.02% | 0.96x | 3.21x | $-3.67 Million |
| 2016 | -91.91% | -37.53% | 0.93x | 2.62x | $-2.63 Million |
| 2017 | -138.29% | -34.09% | 1.00x | 4.06x | $-2.15 Million |
| 2018 | -49.51% | -25.51% | 0.77x | 2.53x | $-1.52 Million |
| 2019 | -5.69% | -3.74% | 0.66x | 2.32x | $-438.40K |
| 2020 | -28.37% | -32.74% | 0.43x | 2.00x | $-1.06 Million |
| 2021 | -47.66% | -42.76% | 0.42x | 2.66x | $-1.17 Million |
| 2022 | -48.74% | -46.13% | 0.40x | 2.63x | $-1.38 Million |
| 2023 | -38.98% | -72.18% | 0.30x | 1.80x | $-1.61 Million |
| 2024 | -112.31% | -87.40% | 0.47x | 2.74x | $-1.96 Million |
Industry Comparison
This section compares Deltex Medical Group plc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $498,972,584
- Average return on equity (ROE) among peers: -54.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Deltex Medical Group plc (DTXMF) | $1.45 Million | 0.00% | 2.02x | $76.40 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-2.23 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $187.53 Billion |
| Acarix AB (publ) (ACIXF) | $51.88 Million | -150.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $3.82 Million |
| Adm Tronics Unltd (ADMT) | $644.00K | 0.00% | 0.66x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $732.88K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $916.00 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $8.41 Million |